United States

Compound Screening Platform


Disease models at molecular, cell and animal levels play critical roles in drug discovery. The biological activity of compounds sourced from chemical synthesis, natural products or biological molecules cannot be tested directly in the human body. The disease models which truthfully reflect the pathology of diseases serve effective and economical ways to explore the activity and corresponding mechanism of the compounds. Boc Sciences is applying more than 200 in vitro and in vivo bioassays of various disease models, including over 100 High-throughput screening (HTS) or high content screening (HCS) models, with the screening capacity reaching approximately 100,000 samples per day. Boc Sciences provides bioassays in: Cancers Cardiovascular diseases Neural system diseases Reproductive system diseases Respiratory system disease Metabolic diseases Infectious diseases

Medical services - specialised
  • Compound Screening Platform
A similar page for your product? Sign up your company and create your own online product pages on EUROPAGES
Sign up